What Cebiphar does

Cebiphar is a French contract research organization founded in 1979 and headquartered in Fondettes, with a second laboratory in Toulouse. It provides analytical and regulatory services to pharmaceutical (human and veterinary), medical device, and contract manufacturing organization (CMO) clients, and has operated as part of Teranga Groupe since 2014. The company employs between 101 and 250 staff across its two sites and is structured as an S.A.S. under French law.

Name

Cebiphar

Legal name

CEBIPHAR S.A.S. (Centre d'études biologiques et pharmaceutiques)

Website

https://cebiphar.com

Company type

Private

Founded year

1979

Operating status

Operating

Headcount range

101–250 employees

Short description

Cebiphar is a French contract research organization founded in 1979, providing GMP/GLP-compliant analytical, microbiological, and regulatory services to pharmaceutical, veterinary, medical device, and CMO clients from laboratories in Fondettes and Toulouse.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Pharmaceutical contract research
• Analytical development services
• Pharmaceutical quality control
• Veterinary clinical studies
• Regulatory affairs consulting

Headquarters

HQ city

Fondettes

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Analytical Development Services: Method development, validation and transfer services for pharmaceutical analytical methods including HPLC, GC, dissolution testing, and spectroscopy. Services are provided on a project basis with customized study designs.
2. Quality Control Testing: Quality control of raw materials, packaging items, and finished products according to pharmacopeial standards (EP, USP, BP, JP). Includes method verification and residual solvent analysis.
3. Stability Studies: ICH and VICH stability studies for pre- and post-marketing authorization, including long-term, intermediate, accelerated conditions, forced degradation, and photo-stability studies.
4. Veterinary Studies: Pre-clinical and clinical veterinary studies including animal models, residue studies, pharmacokinetics, tolerance studies, and GCP-compliant field trials.
5. Technical and Regulatory Support: Regulatory consultancy including dossier audits, gap analysis, CMC file assessment, market authorization filing, IMPD dossier writing, and variations strategy.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Cebiphar is a French Contract Research Organization (CRO) providing analytical and regulatory support services to the pharmaceutical (human and veterinary), medical device, and biotech industries. Its core offering spans method development, validation and transfer, quality control testing, ICH/VICH stability studies, biopharmaceutical quality control, applied microbiology, veterinary pre-clinical and clinical studies, and technical-regulatory consultancy. Services are delivered from two harmonized GMP/GLP-certified sites in Fondettes and Toulouse.

Product overview

CEBIPHAR is a French Contract Research Organization (CRO) founded in 1979, providing comprehensive analytical and regulatory services to the pharmaceutical (human and veterinary) and medical device industries. The company operates two sites (Fondettes and Toulouse, France) and offers an integrated service portfolio organized around four main pillars: (1) Analytical Support including method Development/Validation/Transfer, Quality Control, and ICH/VICH Stability Studies; (2) Biopharmaceutical Quality Control for protein-based therapeutics; (3) Applied Microbiology with antibiotic titration and MIC studies; and (4) Veterinary Studies comprising animal models, pre-clinical and clinical studies. A fifth pillar, Technical and Regulatory Support, provides dossier preparation and regulatory strategy services. As part of TERANGA Groupe alongside ACM Pharma and UPS Consultants, CEBIPHAR delivers end-to-end solutions from drug development through commercialization, with recognized expertise in particle analysis, extractables & leachables, container closure integrity testing, and sterility testing.

Differentiator

Problem solved

Functional benefit

Products and services

• Analytical Development, Validation & Transfer Comprehensive analytical method development, validation, and technology transfer services following ICH Q2(R1) guidelines. Includes forced degradation studies, robustness assessment, and protocol design with statistical interpretation. Offered to pharmaceutical companies developing and manufacturing human and veterinary medicinal products.
• Quality Control Testing Quality control of raw materials, packaging items, and finished products according to European, US, British, Japanese, and Chinese Pharmacopeias. Includes method verification, residual solvents analysis, and import testing for pharmaceutical manufacturers.
• Biopharmaceutical Quality Control Specialized quality control services for biopharmaceutical products from Drug Substance to Drug Product, including protein characterization (SEC, iCIEF, peptide mapping, ELISA), aggregation analysis, residual impurities, extractables & leachables studies, and container closure integrity testing. Includes specialized capabilities for mRNA vaccine analysis.
• ICH / VICH Stability Studies Pre- and post-marketing stability studies supporting clinical trial authorizations and registration dossiers. Covers all ICH and VICH storage conditions including long-term, intermediate, accelerated conditions, forced degradation, and photo-stability studies for pharmaceutical and veterinary products.
• Cleaning Validation Cleaning validation strategy development and analytical method validation for pharmaceutical manufacturing sites. Includes worst-case determination, sampling technique development, and recovery studies.
• Troubleshooting & IP Infringement Management Diagnostic and resolution services for production site issues including OOS (Out-of-Specification) results, method optimization, and technical support for intellectual property cases. Includes benchmarking and expert reports for legal actions.
• Microbiology Services Microbiological antibiotic titrations, MIC/MBC determination (per EUCAST and CLSI recommendations), and strain bank supply. Routine testing of 14+ antibiotics with 3,500 samples/year capacity. Includes method development, validation, and transfer services for pharmaceutical testing laboratories.
• Animal Models Over 20 experimental models developed over 40 years for veterinary pharmaceutical development, including mastitis models (dairy cows), infectious disease models (pigs, poultry), and pathogenic strain models across multiple animal species.
• Veterinary Pre-clinical Studies Pre-clinical veterinary CRO services including local tolerance, pharmacokinetics, residue studies, and clinical pharmacology in target species under GLP conditions. Supports veterinary pharmaceutical development for production and companion animals.
• Veterinary Clinical Studies Clinical field trial management for production and companion animals in GCP compliance (VICH GL9). Includes efficiency studies, tolerance studies, palatability studies, and pharmacovigilance under study for veterinary pharmaceutical companies.
• Technical and Regulatory Support Regulatory consultancy including dossier audits, gap analysis, Market Authorization file writing (modules 3 and 2.3), CEP dossier preparation, IMPD dossier, and variation strategy. Involves Qualified Person and Technical Director. Serves pharmaceutical companies preparing regulatory submissions.
• Hyaluronic Acid Dosage Service Analytical service for hyaluronic acid dosage in injectable medical devices, providing reliable, precise, and reproducible quality control solutions for medical device manufacturers in aesthetic medicine and orthopedics.
• CCIT Validation Service Container Closure Integrity Testing (CCIT) validation service for various pharmaceutical packaging, providing validation reports accepted by French ANSM for variation submissions.

Quantifiable outcome

• 94% client satisfaction rate maintained over 4 years
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core, supporting and major.

• Teranga GroupecoreStrategic or Co-development Partner · 1 January 2014Cebiphar joined TERANGA Groupe in 2014 alongside ACM PHARMA and UPS Consultants. Teranga is an independent holding company combining group synergy with flexibility of human-sized companies. The three entities form a leading group dedicated to human and veterinary healthcare and cosmetic industries throughout Europe.
• ACM PHARMAcoreStrategic or Co-development PartnerSister company within TERANGA Groupe specializing in contamination control. ACM PHARMA provides complementary expertise in microbiology and contamination management, working synergistically with Cebiphar's analytical services.
• UPS ConsultantscoreImplementation/ SI/ Consulting PartnerSister company within TERANGA Groupe providing training, consulting, audits, and technical assistance services. Offers more than 20 years of expertise in cleaning validation strategy and regulatory compliance consulting.
• EyliopharmasupportingChannel Partner/ Reseller/ DistributorPartner for supply of comparator products, import and release of clinical and commercial batches in Europe. Part of Cebiphar's network of partners for comprehensive pharmaceutical services.
• GTP BiowayssupportingChannel Partner/ Reseller/ DistributorPartner for injectables manufacturing (clinical and commercial batches). Extends Cebiphar's service offering to include manufacturing capabilities for pharmaceutical clients.
• Aguettant pharmaceutical laboratorymajorStrategic or Co-development PartnerSelected by Aguettant pharmaceutical laboratory to provide analytical support including development, method validation, and stability studies for 4 essential injectable products. This partnership contributes to the acceleration of essential drug development as part of the French government recovery plan.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Eurofins Scientific: Global leader in bioanalytical and pharmaceutical testing services. Direct overlap with Cebiphar's analytical/QC/stability/microbiology services, but Eurofins operates at vastly larger scale across multiple industries and geographies.
• Pharmaceutical Product Development (PPD, Thermo Fisher): Global CRO offering clinical, preclinical, and laboratory services to pharma and biotech. Adjacent in analytical/QC testing though PPD's core scale is in full clinical trial operations that Cebiphar does not offer.
• Charles River Laboratories: Major preclinical and discovery CRO with strong veterinary and safety assessment capabilities. Overlaps with Cebiphar's veterinary pre-clinical and GLP-certified work, but operates as a full-service global CRO spanning discovery through manufacturing.
• SGS (Life Sciences division): Major testing and inspection company with a Life Sciences division offering pharmaceutical analytical, microbiology, and clinical services. Comparable in service mix but operates globally at significantly larger scale than Cebiphar.

Direct peers

• PharmaLex (Cencora): Regulatory affairs and consulting CRO providing dossier writing, gap analysis, and submission support — a direct match for Cebiphar's Technical and Regulatory Support service line. Comparable in project-based consulting model though broader in regulatory coverage.
• Antellis: French analytical CRO providing pharmaceutical quality control, method development, and regulatory support services. Closely comparable service offering, scale, and French regulatory positioning to Cebiphar.
• Intertek (Life Sciences): Provides pharmaceutical quality control, analytical method validation, stability, and regulatory support services. Closely comparable service portfolio to Cebiphar with similar project-based B2B motion, though Intertek is a much larger global incumbent.
• IDVet: French veterinary diagnostics company developing tests for livestock and companion animals. Shares Cebiphar's veterinary specialization and French base, though focused on diagnostic kits rather than CRO testing services.

Others

• Veeva Systems: Cloud software provider for life sciences with strong regulatory and quality management offerings. Not a testing peer, but a complementary technology provider whose regulated-content and quality platforms often co-purchase with CRO services like Cebiphar's.
• Vetoquinol: French veterinary pharmaceutical company headquartered near Paris. Not a direct CRO peer, but a representative target customer for Cebiphar's veterinary analytical services and a benchmark for French veterinary pharma scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cebiphar
• Xx.com/cebiphar1

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cebiphar